Delayed First Injection Of The Once-a-month Injectable Contraceptive Containing 25 Mg Of Medroxyprogesterone Acetate And 5 Mg Of E(2)-cypionate: Effects On Ovarian Function.

dc.creatorPetta, C A
dc.creatorHays, M
dc.creatorBrache, V
dc.creatorMassai, R
dc.creatorHua, Y
dc.creatorAlvarez-Sánchez, F
dc.creatorCroxatto, H
dc.creatord'Arcangues, C
dc.creatorCook, L A
dc.creatorBahamondes, L
dc.date2001-Apr
dc.date2015-11-27T12:29:14Z
dc.date2015-11-27T12:29:14Z
dc.date.accessioned2018-03-29T00:55:52Z
dc.date.available2018-03-29T00:55:52Z
dc.identifierFertility And Sterility. v. 75, n. 4, p. 744-8, 2001-Apr.
dc.identifier0015-0282
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/11287029
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/194976
dc.identifier11287029
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1295209
dc.descriptionTo assess whether women who were administered the first injection of DMPA+E(2)C on day 7 of their menstrual cycle (delayed injection) exhibit the same degree of ovarian suppression as women who receive it on day 5 of their menstrual cycle. Multicenter, randomized controlled trial. Reproductive health clinics. Women aged between 18 and 38 years (inclusive) willing to use DMPA+E(2)C as their method of contraception. Participants received a DMPA+E(2)C injection on day 5 (control group, n = 41) or day 7 (delayed-injection group, n = 117) of their menstrual cycle. Ovarian activity and follicular development determined by serial serum progesterone levels and vaginal ultrasound. Participants who received DMPA+E(2)C on day 5 of their menstrual cycle (control group) exhibited no more than limited follicular growth (no follicle >16 mm). Of those women who received DMPA+E(2)C on day 7 of their menstrual cycle (delayed-injection group), 21 (18%) showed some follicular growth, of whom 4 (3%) ovulated. The first injection of DMPA+E(2)C given on day 7 of a menstrual cycle does not provide the same inhibition of ovarian activity as that observed when it is administered on day 5 of the menstrual cycle.
dc.description75
dc.description744-8
dc.languageeng
dc.relationFertility And Sterility
dc.relationFertil. Steril.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAge Factors
dc.subjectBody Mass Index
dc.subjectContraceptive Agents, Female
dc.subjectDelayed-action Preparations
dc.subjectEstradiol
dc.subjectFemale
dc.subjectHumans
dc.subjectMedroxyprogesterone Acetate
dc.subjectMenstrual Cycle
dc.subjectOvarian Follicle
dc.subjectOvary
dc.subjectOvulation
dc.subjectProgesterone
dc.titleDelayed First Injection Of The Once-a-month Injectable Contraceptive Containing 25 Mg Of Medroxyprogesterone Acetate And 5 Mg Of E(2)-cypionate: Effects On Ovarian Function.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución